Parameter
| Biomarker | HER2 & ATM | Full name | Human Epidermal Growth Factor Receptor 2 / Ataxia Telangiectasia Mutated | Molecular Type | Protein |
|---|---|---|---|---|---|
| Molecular Formula | / | Molecular Weight | / | Core Functional Dimensions | Prognosis & therapeutic targets |
| Disease | Bladder Cancer (BC) | Disease Subtypes | / | ||
| Organ | Bladder | Test Sample / Technology Platform | Tissue (detection platform not specified) | ||
| Pathobiological Mechanisms | HER2 interacts with ATM; ATM is an independent prognostic marker; both associated with survival & cancer aggressiveness | ||||
| Clinical Availability Status | Research verification stage | ||||
| Notes and Dynamics | Combination targets for bladder cancer; mechanism & clinical validation ongoing | ||||